GIM
WVE icon

Glenmede Investment Management’s Wave Life Sciences WVE Stock Holding History

Glenmede Investment Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$324K Sell
44,326
-8,695
-16% -$70.3K ﹤0.01% 1093
2025
Q2 		$345K Buy
+53,021
New +$350K ﹤0.01% 1060

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Glenmede Investment Management's WVE Position: Q3 2025 in Review

Glenmede Investment Management reduced its Wave Life Sciences (WVE) stake by 16% in Q3 2025, selling an estimated $70.3K and leaving 44,326 shares worth $324K. The position accounts for ﹤0.01% of the portfolio, ranked #1093.

Glenmede Investment Management first reported a position in WVE in Q2 2025 and has held it in 2 quarters since. The position peaked at $345K in Q2 2025. 189 funds tracked by Wall St. Rank hold WVE as of Q3 2025.

  • Glenmede Investment Management held 44,326 shares of Wave Life Sciences worth $324K as of Q3 2025.
  • Glenmede Investment Management sold 8,695 Wave Life Sciences shares in Q3 2025, an estimated $70.3K.
  • Wave Life Sciences made up ﹤0.01% of Glenmede Investment Management's portfolio in Q3 2025, its #1093 holding.
  • Glenmede Investment Management first reported a position in Wave Life Sciences in Q2 2025 and has held it in 2 quarters since.
  • Glenmede Investment Management's Wave Life Sciences position peaked at $345K in Q2 2025.
  • 189 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.